GlassScriptPhysician profile
Roger T Tomihama
NPI 1912199068
$2,310.97
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $157 · 2021: $186 · 2022: $450 · 2023: $235 · 2024: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $511.25 | 2019-2024 | Alto Abdominal Stent Graft System |
| Inari Medical, INC. | $496.31 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $381.00 | 2019-2024 | Lutonix Drug Coated Balloon |
| Medtronic, INC. | $158.34 | 2024 | Concertotm |
| Silk Road Medical, INC. | $142.16 | 2020 | |
| Shockwave Medical, INC | $141.25 | 2022 | |
| Abbott Laboratories | $130.33 | 2019 | |
| Boston Scientific Corporation | $120.00 | 2021-2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Medtronic Vascular, INC. | $88.63 | 2019-2020 | |
| Angiodynamics, INC. | $60.16 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Penumbra, INC. | $52.63 | 2024 | Benchmark |
| Terumo Medical Corporation | $28.91 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Tomihama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.